Karschin A, Aizenman E, Lipton S A
Max-Planck-Institut für Hirnforschung, Frankfurt/M., FRG.
J Neurosci. 1988 Aug;8(8):2895-906. doi: 10.1523/JNEUROSCI.08-08-02895.1988.
The pharmacological properties of the interaction between the excitatory amino acid (EAA) analogs kainate and N-methyl-D-aspartate (NMDA) have been examined on the isolated rat retinal ganglion cell preparation. In addition, we have studied the effects on this interaction of 2 noncompetitive NMDA antagonists, the dissociative anesthetic phencyclidine (PCP) and the anticonvulsant MK-801. Electrophysiological measurements were performed with the whole-cell patch-clamp technique on cultured ganglion cells that had been back-labeled with a fluorescent dye. Whereas only 69% of the cells showed responses to NMDA (in the absence of extracellular Mg2+), every ganglion cell responded to kainate under the same conditions. When a given cell was voltage-clamped at -60 mV, the large inward currents elicited by 125 microM kainate generally exceeded the responses evoked by 200 microM NMDA, when present, by 1 or 2 orders of magnitude. There was a poor correlation between the magnitudes of the currents produced by both agonists for the population of cells tested. Furthermore, NMDA proved to be an antagonist for the kainate receptor binding site. Without influencing the kainate-activated currents, PCP (75 microM) and MK-801 (20 microM) completely and reversibly blocked the responses evoked by NMDA (200 microM), independent of the membrane holding potential. The degree of block produced by a submaximal concentration of either antagonist was accentuated by increasing the concentration of NMDA. The independence of NMDA and kainate currents was examined. In the presence of NMDA and PCP (or MK-801), kainate-induced responses were comparable in amplitude to those generated by the application of kainate and NMDA together. Thus, kainate continued to produce an increase in membrane conductance at a time when NMDA-activated currents were blocked by either antagonist. The NMDA antagonism of kainate-induced currents was shown to be constant and independent of PCP or MK-801. Our results suggest that the 2 EAA analogs might not share a common ionophore, but rather activate separate receptor-ion channel complexes in rat retinal ganglion cell membranes.
在分离的大鼠视网膜神经节细胞标本上,研究了兴奋性氨基酸(EAA)类似物海人酸和N-甲基-D-天冬氨酸(NMDA)之间相互作用的药理学特性。此外,我们还研究了2种非竞争性NMDA拮抗剂——分离麻醉剂苯环利定(PCP)和抗惊厥药MK-801对这种相互作用的影响。采用全细胞膜片钳技术,对用荧光染料进行逆向标记的培养神经节细胞进行电生理测量。在没有细胞外镁离子的情况下,只有69%的细胞对NMDA有反应,而在相同条件下,每个神经节细胞对海人酸都有反应。当将给定细胞钳制在-60 mV电压时,125 μM海人酸引发的大内向电流通常比200 μM NMDA(如果存在)引发的反应大1或2个数量级。在所测试的细胞群体中,两种激动剂产生的电流大小之间相关性较差。此外,NMDA被证明是海人酸受体结合位点的拮抗剂。在不影响海人酸激活电流的情况下,PCP(75 μM)和MK-801(20 μM)完全且可逆地阻断了200 μM NMDA引发的反应,且与膜钳制电位无关。通过增加NMDA浓度,可增强任一拮抗剂亚最大浓度所产生的阻断程度。研究了NMDA和海人酸电流的独立性。在存在NMDA和PCP(或MK-801)的情况下,海人酸诱导的反应幅度与同时应用海人酸和NMDA时产生的反应幅度相当。因此,当NMDA激活电流被任一拮抗剂阻断时,海人酸仍能使膜电导增加。NMDA对海人酸诱导电流的拮抗作用表现为恒定,且与PCP或MK-801无关。我们的结果表明,这两种EAA类似物可能不共享一个共同的离子通道,而是激活大鼠视网膜神经节细胞膜中不同的受体-离子通道复合物。